ArticleEye (London, England)2026
Comparative evaluation of MRI Dixon T2-weighted, T2 mapping, and T1 mapping for Graves' ophthalmopathy activity assessment.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to compare the diagnostic performance of Dixon T2-weighted imaging (Dixon-T2WI), T2 mapping, and T1 mapping in evaluating orbital activity in Graves' orbitopathy (GO).
methodsSeventy-three GO patients were retrospectively enrolled, with 146 affected eyes. Based on clinical activity score (CAS) criteria, the eyes were divided into inactive (n = 76) and active (n = 70) groups. All patients underwent orbital magnetic resonance imaging (MRI) with Dixon-T2WI, T1 mapping, and T2 mapping sequences. The signal intensity ratio (SIR), T2 relaxation time (T2RT), and T1 relaxation time (T1RT) were measured in the superior rectus (SR), inferior rectus (IR), lateral rectus (LR), and medial rectus (MR). Predicted probabilities were derived from the generalised linear mixed model. Diagnostic performance was evaluated via marginal area under the receiver operating characteristic (ROC) curve (AUC), with pairwise comparisons by DeLong's test.
resultsROC curve analysis showed the following: The AUC values of the MR-SIR (AUC = 0.742) showed no significant difference from T2RT (P > 0.05), and both were higher than T1RT. The AUC values of the SR-SIR (AUC = 0.770) showed no significant difference from T2RT (P > 0.05), and both were higher than T1RT. The AUC value of the IR-SIR (AUC = 0.823) showed no significant difference from T2RT (P > 0.05), and both were higher than T1RT. The AUC values of the LR-SIR (AUC = 0.700) showed no significant difference among SIR, T2RT, and T1RT (all P > 0.05).
conclusionAs a routine sequence, Dixon-T2WI is comparable to T2 mapping in diagnostic efficacy and significantly superior to T1 mapping. It is preferred for assessing GO activity in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.